Cellavita is a clinical-stage Biotechnology company operating in Brazil and the USA, focused on developing disruptive and innovative Advanced Cell Therapy products for the treatment of life-threatening rare diseases, as well as products for significant unmet medical needs.

"We are passionate about cells!"

We know there is a significant unmet need for effective therapies for those whose lives are disrupted by highly debilitating and often fatal rare diseases.

Using the NestaCell® technological platform, Cellavita® is focused on developing a range of heterologous Advanced Cell Therapy products that can change the lives of people with highly debilitating conditions.

Strategic Partnerships:

Cellavita has brought together a group of experts from around the world to form a Scientific Committee that will guide the paths of clinical investigation for the company going forward, as Cellavita intends to conduct studies in a multicentric and international manner as well.